<DOC>
	<DOCNO>NCT01463358</DOCNO>
	<brief_summary>Study Objective The purpose study evaluate efficacy bradycardia pace respect patient symptom patient bifascicular block syncope unexplained origin .</brief_summary>
	<brief_title>Prevention Syncope Cardiac Pacing Patients With Bifascicular Block</brief_title>
	<detailed_description>Primary endpoint First occurrence composite Syncope origin OR Presyncopal episode document cardioinhibitory origin OR Atrioventricular block degree ; associate patient symptom Design : - Randomized , prospective , single blind , two parallel arm - Treatment group : DDD60 - program DDD mode / 60 low limit - Control Group : DDI30 - program DDI mode / 30 low limit - Randomization type : block randomization : Block size : 4 , allocation ratio 1:1 Sample : 100 patient Population - Patients bifascicular block least one syncopal episode within last 6 month precede enrollment . - Patients negative series pre-enrollment screen order exclude : - Brady-tachy syndrome , vasovagal syncope carotid sinus syndrome , atrial fibrillation , inducible AV block - Ejection fraction &gt; =40 % - Mean nocturnal heart rate &gt; =35 bpm</detailed_description>
	<mesh_term>Syncope</mesh_term>
	<criteria>Evidence Bifascicular block At least one episode syncope last 6 month enrollment Patients Bradytachy syndrome need pacemaker prevent symptomatic bradycardia symptomatic tachycardia arrhythmia Patients vasovagal syndrome positive TTT carotid sinus syndrome Patients Chronic Atrial Fibrillation Patients Atrial Ventricular Block induces EPS</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Syncope</keyword>
	<keyword>Bifascicular block</keyword>
	<keyword>Bradycardia pacing</keyword>
</DOC>